Cowen and Company’s Medtronic MDT Stock Holding History

Cowen and Company’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-29,150	Closed	-$3.17M	–	540
2019 Q3	$3.17M	Buy	+29,150	New	+$3.04M	0.8%	18

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cowen and Company's MDT Position: Q4 2019 in Review

Cowen and Company sold out of Medtronic (MDT) in Q4 2019, closing a stake of 29,150 shares — an estimated $3.17M sold.

Cowen and Company first reported a position in MDT in Q3 2019 and held it in 1 quarter. The position peaked at $3.17M in Q3 2019. 1,821 funds tracked by Wall St. Rank hold MDT as of Q4 2019.

Cowen and Company reported no remaining Medtronic position as of Q4 2019 after selling out during the quarter.
Cowen and Company sold 29,150 Medtronic shares in Q4 2019, an estimated $3.17M.
Cowen and Company first reported a position in Medtronic in Q3 2019 and held it in 1 quarter.
Cowen and Company's Medtronic position peaked at $3.17M in Q3 2019.
1,821 funds tracked by Wall St. Rank held Medtronic as of Q4 2019.

Based on Cowen and Company's 13F filing for Q4 2019, filed 11 Feb 2020.